Clinical Trial Update: HS-20093 in Patients with Advanced Esophageal Carcinoma and Other Advanced Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of HS-20093 in patients with advanced esophageal cancer and other advanced solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• HS-20093

Snippet

Sponsor: Hansoh BioMedical R&D Company | Conditions: Advanced Solid Tumor | Phase 2 | Status: RECRUITING